Mediwound Historical Income Statement

MDWD Stock

USD 17.47 0.02 0.11%

Historical analysis of Mediwound income statement accounts such as Other Operating Expenses of 22.4 M can show how well Mediwound performed in making a profits. Evaluating Mediwound income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mediwound's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Mediwound latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mediwound is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

About Mediwound Income Statement Analysis

Mediwound Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mediwound shareholders. The income statement also shows Mediwound investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Mediwound Income Statement Chart

At present, Mediwound's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Discontinued Operations is expected to grow to about 96.6 K, whereas Interest Expense is forecasted to decline to about 405.6 K.

Selling General Administrative Other Operating Expenses Research Development Total Operating Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mediwound. It is also known as Mediwound overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Mediwound's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mediwound current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.At present, Mediwound's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Discontinued Operations is expected to grow to about 96.6 K, whereas Interest Expense is forecasted to decline to about 405.6 K.

	2021	2022	2023	2024 (projected)
Interest Expense	903K	8.9M	427K	405.7K
Depreciation And Amortization	1.2M	1.3M	1.3M	810.5K

Interest Expense Depreciation And Amortization

Mediwound income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Cost Of Revenue	Discontinued Operations	Selling And Marketing Expenses	Total Revenue	Gross Profit	Net Income From Continuing Ops	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.32	0.51	0.92	-0.02	-0.08	0.83	-0.02	0.72	-0.18	-0.3	-0.07	0.04	0.9	0.65	-0.14	0.93	0.76	-0.02	-0.16	0.48	-0.1	0.93
Interest Expense	0.32		0.02	0.31	0.05	-0.37	0.43	-0.35	0.31	-0.35	-0.6	-0.33	0.09	0.29	0.13	-0.21	0.33	0.36	-0.33	-0.29	0.15	-0.38	0.31
Selling General Administrative	0.51	0.02		0.62	-0.47	-0.5	0.58	-0.47	0.73	-0.54	-0.24	-0.42	0.08	0.18	0.42	0.6	0.33	0.24	-0.38	-0.19	-0.11	-0.07	0.28
Other Operating Expenses	0.92	0.31	0.62		-0.34	-0.38	0.92	-0.33	0.92	-0.46	-0.39	-0.36	0.17	0.79	0.55	0.15	0.8	0.6	-0.33	-0.14	0.29	-0.03	0.83
Operating Income	-0.02	0.05	-0.47	-0.34		0.81	-0.4	0.8	-0.61	0.75	-0.05	0.73	-0.24	0.14	0.06	-0.72	0.28	0.5	0.87	-0.27	0.36	-0.46	0.11
Ebit	-0.08	-0.37	-0.5	-0.38	0.81		-0.55	1.0	-0.65	0.89	0.38	0.85	-0.22	0.12	0.1	-0.63	0.16	0.3	0.96	0.22	0.42	0.05	0.1
Research Development	0.83	0.43	0.58	0.92	-0.4	-0.55		-0.51	0.87	-0.62	-0.51	-0.52	0.24	0.7	0.43	0.11	0.67	0.47	-0.49	-0.26	0.2	-0.1	0.74
Ebitda	-0.02	-0.35	-0.47	-0.33	0.8	1.0	-0.51		-0.61	0.88	0.37	0.85	-0.22	0.17	0.13	-0.64	0.21	0.35	0.95	0.22	0.45	0.05	0.15
Total Operating Expenses	0.72	0.31	0.73	0.92	-0.61	-0.65	0.87	-0.61		-0.7	-0.41	-0.62	0.27	0.51	0.39	0.48	0.53	0.35	-0.59	-0.12	-0.01	0.01	0.56
Income Before Tax	-0.18	-0.35	-0.54	-0.46	0.75	0.89	-0.62	0.88	-0.7		0.59	0.95	-0.49	0.0	-0.08	-0.61	0.03	0.17	0.81	0.23	0.29	0.09	0.0
Total Other Income Expense Net	-0.3	-0.6	-0.24	-0.39	-0.05	0.38	-0.51	0.37	-0.41	0.59		0.58	-0.56	-0.28	-0.05	-0.02	-0.37	-0.43	0.2	0.6	0.08	0.6	-0.24
Net Income	-0.07	-0.33	-0.42	-0.36	0.73	0.85	-0.52	0.85	-0.62	0.95	0.58		-0.66	0.05	0.15	-0.53	0.13	0.24	0.79	0.19	0.44	0.06	0.08
Income Tax Expense	0.04	0.09	0.08	0.17	-0.24	-0.22	0.24	-0.22	0.27	-0.49	-0.56	-0.66		0.14	-0.32	0.01	0.02	0.0	-0.2	0.02	-0.34	0.06	0.05
Cost Of Revenue	0.9	0.29	0.18	0.79	0.14	0.12	0.7	0.17	0.51	0.0	-0.28	0.05	0.14		0.5	-0.42	0.9	0.74	0.13	-0.04	0.6	0.0	0.94
Discontinued Operations	0.65	0.13	0.42	0.55	0.06	0.1	0.43	0.13	0.39	-0.08	-0.05	0.15	-0.32	0.5		0.07	0.62	0.53	0.14	-0.05	0.78	-0.14	0.58
Selling And Marketing Expenses	-0.14	-0.21	0.6	0.15	-0.72	-0.63	0.11	-0.64	0.48	-0.61	-0.02	-0.53	0.01	-0.42	0.07		-0.32	-0.36	-0.57	-0.07	-0.45	0.02	-0.37
Total Revenue	0.93	0.33	0.33	0.8	0.28	0.16	0.67	0.21	0.53	0.03	-0.37	0.13	0.02	0.9	0.62	-0.32		0.94	0.23	-0.22	0.56	-0.24	0.94
Gross Profit	0.76	0.36	0.24	0.6	0.5	0.3	0.47	0.35	0.35	0.17	-0.43	0.24	0.0	0.74	0.53	-0.36	0.94		0.41	-0.32	0.48	-0.41	0.8
Net Income From Continuing Ops	-0.02	-0.33	-0.38	-0.33	0.87	0.96	-0.49	0.95	-0.59	0.81	0.2	0.79	-0.2	0.13	0.14	-0.57	0.23	0.41		-0.05	0.36	-0.21	0.08
Interest Income	-0.16	-0.29	-0.19	-0.14	-0.27	0.22	-0.26	0.22	-0.12	0.23	0.6	0.19	0.02	-0.04	-0.05	-0.07	-0.22	-0.32	-0.05		0.2	0.93	0.02
Extraordinary Items	0.48	0.15	-0.11	0.29	0.36	0.42	0.2	0.45	-0.01	0.29	0.08	0.44	-0.34	0.6	0.78	-0.45	0.56	0.48	0.36	0.2		0.05	0.61
Net Interest Income	-0.1	-0.38	-0.07	-0.03	-0.46	0.05	-0.1	0.05	0.01	0.09	0.6	0.06	0.06	0.0	-0.14	0.02	-0.24	-0.41	-0.21	0.93	0.05		0.05
Reconciled Depreciation	0.93	0.31	0.28	0.83	0.11	0.1	0.74	0.15	0.56	0.0	-0.24	0.08	0.05	0.94	0.58	-0.37	0.94	0.8	0.08	0.02	0.61	0.05

Click cells to compare fundamentals

Mediwound Account Relationship Matchups

Mediwound income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.2M	1.1M	1.2M	1.3M	1.3M	810.5K
Interest Expense	925K	832K	903K	8.9M	427K	405.7K
Selling General Administrative	9.3M	8.7M	6.1M	8.3M	8.6M	7.8M
Other Operating Expenses	27.3M	30.6M	35.0M	34.8M	34.0M	22.4M
Operating Income	4.5M	(8.8M)	(11.2M)	(8.3M)	(15.3M)	(16.1M)
Ebit	4.5M	(8.8M)	(12.5M)	(19.4M)	(6.2M)	(6.5M)
Research Development	5.0M	7.7M	10.3M	10.2M	7.5M	6.5M
Ebitda	5.6M	(7.8M)	(11.2M)	(18.1M)	(4.9M)	(5.1M)
Total Operating Expenses	15.4M	16.4M	20.0M	21.5M	18.9M	15.6M
Income Before Tax	2.1M	(9.3M)	(13.5M)	(19.5M)	(6.5M)	(6.9M)
Total Other Income Expense Net	(2.4M)	(436K)	(2.3M)	(11.2M)	8.8M	9.2M
Net Income	3.7M	(9.6M)	(13.6M)	(19.6M)	(6.7M)	(7.1M)
Income Tax Expense	(1.7M)	325K	27K	78K	185K	194.3K
Cost Of Revenue	11.8M	14.2M	15.0M	13.3M	15.1M	8.3M
Net Income Applicable To Common Shares	5.0M	(9.2M)	(13.6M)	(19.6M)	(17.6M)	(18.5M)
Selling And Marketing Expenses	4.1M	3.2M	3.4M	2.0M	2.8M	3.9M
Total Revenue	31.8M	21.8M	23.8M	26.5M	18.7M	13.1M
Gross Profit	19.9M	7.5M	8.8M	13.2M	3.6M	5.0M
Net Income From Continuing Ops	2.1M	(9.3M)	(13.6M)	(19.6M)	(12.4M)	(13.1M)
Interest Income	434K	297K	11K	270K	2.3M	2.5M
Net Interest Income	(2.5M)	(549K)	(1.1M)	(2.3M)	5.9M	6.2M
Reconciled Depreciation	1.1M	1.1M	1.2M	1.3M	1.2M	1.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:

How To Invest In Mediwound

Details

Is Mediwound Stock a good investment?

Details

What is Mediwound's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.91)

Revenue Per Share

2.18

Quarterly Revenue Growth

0.061

Return On Assets

(0.16)

Return On Equity

(0.76)

The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mediwound Historical Income Statement

About Mediwound Income Statement Analysis

Mediwound Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Mediwound income statement Correlations

Mediwound Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mediwound income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 1.0	Ebit
Net Income From Continuing Ops	+ 0.96	Ebit
Net Income From Continuing Ops	+ 0.95	Ebitda
Net Income	+ 0.95	Income Before Tax
Reconciled Depreciation	+ 0.94	Cost Of Revenue
Gross Profit	+ 0.94	Total Revenue

Selling And Marketing Expenses	- 0.72	Operating Income
Income Before Tax	- 0.7	Total Operating Expenses
Income Tax Expense	- 0.66	Net Income
Total Operating Expenses	- 0.65	Ebit
Selling And Marketing Expenses	- 0.64	Ebitda
Selling And Marketing Expenses	- 0.63	Ebit